Brokerages Set agilon health, inc. (NYSE:AGL) Price Target at $3.95

agilon health, inc. (NYSE:AGL) has been given a consensus rating of “Hold” by the seventeen ratings firms that are presently covering the firm, Marketbeat Ratings reports. Two equities research analysts have rated the stock with a sell recommendation, thirteen have issued a hold recommendation and two have issued a buy recommendation on the company. The average 12-month price target among analysts that have issued a report on the stock in the last year is $3.95.

Several research firms recently issued reports on AGL. Royal Bank of Canada upped their target price on agilon health from $3.00 to $3.50 and gave the company an “outperform” rating in a research report on Wednesday, February 26th. Citigroup raised agilon health from a “sell” rating to a “neutral” rating and upped their target price for the company from $1.75 to $2.25 in a research report on Friday, January 10th. Stifel Nicolaus upped their target price on agilon health from $2.00 to $3.00 and gave the company a “hold” rating in a research report on Wednesday, February 26th. Macquarie began coverage on shares of agilon health in a report on Monday, December 16th. They issued a “neutral” rating and a $3.00 price target on the stock. Finally, Needham & Company LLC reaffirmed a “hold” rating on shares of agilon health in a report on Wednesday, February 26th.

Institutional Investors Weigh In On agilon health

Several hedge funds have recently modified their holdings of the company. Vanguard Group Inc. boosted its stake in shares of agilon health by 0.9% during the 4th quarter. Vanguard Group Inc. now owns 31,112,407 shares of the company’s stock worth $59,114,000 after acquiring an additional 272,787 shares in the last quarter. Capital International Investors boosted its stake in shares of agilon health by 72.0% during the 4th quarter. Capital International Investors now owns 22,331,873 shares of the company’s stock worth $42,431,000 after acquiring an additional 9,346,295 shares in the last quarter. State Street Corp raised its position in shares of agilon health by 3.0% during the 3rd quarter. State Street Corp now owns 7,449,706 shares of the company’s stock worth $29,277,000 after purchasing an additional 215,733 shares during the last quarter. Millennium Management LLC raised its position in shares of agilon health by 187.8% during the 4th quarter. Millennium Management LLC now owns 7,212,525 shares of the company’s stock worth $13,704,000 after purchasing an additional 4,706,357 shares during the last quarter. Finally, Geode Capital Management LLC raised its position in shares of agilon health by 0.5% during the 4th quarter. Geode Capital Management LLC now owns 6,928,724 shares of the company’s stock worth $13,168,000 after purchasing an additional 35,207 shares during the last quarter.

agilon health Price Performance

NYSE AGL opened at $4.08 on Monday. The company has a debt-to-equity ratio of 0.06, a current ratio of 1.29 and a quick ratio of 1.29. The stock’s fifty day moving average price is $3.30 and its 200 day moving average price is $2.93. agilon health has a 1 year low of $1.50 and a 1 year high of $7.73. The company has a market cap of $1.68 billion, a price-to-earnings ratio of -4.34 and a beta of 0.67.

agilon health Company Profile

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.